SCHEMBL7598726

SCHEMBL7598726

CCCOc1ccc(-c2sc3c(c2CNS(=O)(=O)CC)c(=O)n(CC(=O)OCC)c(=O)n3Cc2ccccc2SC)cc1

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GNRHR P30968 7/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 4/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KDM4E B2RXH2 1/20 0.32
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
POLB P06746 1/20 0.31
EDNRB P24530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7593455 0.95 GNRHR (0.36) L3MBTL1MAPTNPSR1GNRHRMEN1
SCHEMBL7595931 0.93 GNRHR (0.36) L3MBTL1MAPTNPSR1GNRHRMEN1
SCHEMBL7593195 0.93 GNRHR (0.37) GNRHRMEN1KMT2AALDH1A1LMNA
SCHEMBL7592385 0.92 GNRHR (0.35) GNRHRMEN1KMT2AEDNRB
SCHEMBL7598723 0.92 GNRHR (0.36) L3MBTL1MAPTNPSR1GNRHRMEN1
SCHEMBL7598751 0.90 GNRHR (0.36) GNRHRMEN1KMT2AALDH1A1LMNA
SCHEMBL7593495 0.89 L3MBTL1 (0.38) L3MBTL1MAPTNPSR1GNRHRMEN1
SCHEMBL7592912 0.87 GNRHR (0.37) GNRHRMEN1KMT2AALDH1A1LMNA
SCHEMBL7597312 0.87 MEN1 (0.36) GNRHRMEN1KMT2AALDH1A1LMNA
SCHEMBL7595053 0.87 GNRHR (0.35) GNRHRMEN1KMT2AEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846119-B1 THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE AS ENDOTHELIN ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-13 EP disclosed
US-6140325-A HAS ENDOTHELIN ANTAGONISTIC ACTION; FOR TREATING LIVER HYPOFUNCTION, ACUTE RENAL INSUFFICIENCY, CARDIAC INFARCTION OR LIVER INSUFFICIENCY, VASOCONSTRICTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-10-31 US disclosed